Cargando…

TLR3 Plays Significant Roles against HBV-Associated HCC

Toll-like receptor 3 (TLR3) is a pattern-recognizing receptor that is involved in immune signaling and plays a crucial role in survival by being able to recognize various viral components including double-stranded RNA (dsRNA). The role of TLR3 in hepatocellular carcinoma (HCC) with hepatitis B virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiao-lan, Xu, Yu-yin, Chen, Li, Wang, Gui-lan, Shen, Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422996/ https://www.ncbi.nlm.nih.gov/pubmed/25983748 http://dx.doi.org/10.1155/2015/572171

Ejemplares similares

A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
por: Xu, Yu-Yin, et al.
Publicado: (2013)

Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
por: Xu, Yu-Yin, et al.
Publicado: (2023)

IL-6 Plays a Crucial Role in HBV Infection
por: Lan, Tian, et al.
Publicado: (2015)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes
por: Yin, Li, et al.
Publicado: (2017)

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
por: Hu, Zili, et al.
Publicado: (2022)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Single-cell analysis reveals HBV-specific PD-1(+)CD8(+) TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
por: Liu, Lulu, et al.
Publicado: (2023)

Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC
por: Bai, Xin, et al.
Publicado: (2018)

AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827
por: CHEN, JIA, et al.
Publicado: (2015)

Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
por: Healy, Katie, et al.
Publicado: (2021)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV
por: Akkiz, H, et al.
Publicado: (2020)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood
por: Lin, Meiyin, et al.
Publicado: (2023)

The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
por: Sartorius, Kurt, et al.
Publicado: (2019)

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD
por: Radmanić, Leona, et al.
Publicado: (2022)

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level
por: Ayub, Ambreen, et al.
Publicado: (2013)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2020)

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
por: Zhao, Zhifeng, et al.
Publicado: (2021)

Circulating Neutrophils Predict Poor Survival for HCC and Promote HCC Progression Through p53 and STAT3 Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2020)

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
por: Lou, Weiyang, et al.
Publicado: (2019)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018)

A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective Cohort Study
por: Yin, Jianhua, et al.
Publicado: (2022)

HBV‐integrated local genomic alterations reveal multicentric independent occurrences of multifocal HCC
por: Zou, Hao, et al.
Publicado: (2023)

The balance between intrahepatic IL-17(+ )T cells and Foxp3(+ )regulatory T cells plays an important role in HBV-related end-stage liver disease
por: Niu, Yinghua, et al.
Publicado: (2011)

Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation
por: Wu, Kejia, et al.
Publicado: (2023)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d6d3q03u477slqqmc242ko0p44